LeonaBio, Inc. (LONA) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$5.23

From 52W high−57.36%

Volume38652.00

Market cap$46.92M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$5.23

From 52W high

−57.36%

Volume

38652.00

Market cap

$46.92M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.1x

P/E (TTM)

—

RSI (14)

41.6

MomentumView details →

1D Return

−4.23%

YTD Return

−34.87%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

0.1x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

1.4x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−421.06%

ROA (TTM)

−248.63%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

+12.41%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+1.98%

EBITDA YoY

+5.17%

MomentumView details →

1D Return

−4.23%

YTD Return

−34.87%

1Y Return

+34.33%

RSI (14)

41.6

vs 50D SMA

−24.75%

vs 200D SMA

−35.04%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

7.01x

Quick Ratio

7.01x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.80

EPS Surprise

42.40%

Beats (12Q)

6/12

Next Q EPS Est

−$0.60

Avg Surprise (4Q)

−323.10%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−141.46M

Op. CF (TTM)

−61.93M

Next earningsNov 5, 2026 →

Latest newsMore news →

LeonaBio reported its financial results for the second quarter of 2026 and provided a business update.66d ago

Similar companies

Clene Inc.CLNN Tevogen Bio Holdings Inc.TVGN Mereo BioPharma Group plcMREO Kalaris Therapeutics IncKLRS ImageneBio IncIMA MiNK Therapeutics, Inc.INKT Find similar companies →

Latest newsMore news →

LeonaBio reported its financial results for the second quarter of 2026 and provided a business update.66d ago